Last updated: April 30, 2024
Sponsor: Medacta International SA
Overall Status: Active - Recruiting
Phase
N/A
Condition
Knee Replacement
Treatment
blood sample
Clinical Study ID
NCT04801654
P.02.01.427
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Those older than 18 years old at the surgery time
- those suitable to undergo to a primary total knee arthroplasty for whom the GMK SphereTiNb coated device will be implanted (according to the labelindication/contraindications)
- Patients who are willing and able to provide written informed consent forparticipation in the study. Written informed consent must be obtained prior topatient's surgery
Exclusion
Exclusion Criteria:
- Those patients with metal implants containing Co, Cr and / or Ni
- Those patients who have had environmental or occupational exposure to toxic metalssuch as Co, Cr and / or Ni (solvents, industrial paints, welders)
- Those whose mental conditions may compromise their ability to provide informed consentto study participation, ability to complete questionnaires or complete 10-yearfollow-ups
- Those unable to give their consent to participate in the study or who do not want toparticipate
- Any condition not mentioned in inclusion criteria.
Study Design
Total Participants: 155
Treatment Group(s): 1
Primary Treatment: blood sample
Phase:
Study Start date:
February 05, 2020
Estimated Completion Date:
December 05, 2033
Connect with a study center
IRCCS Istituto Ortopedico Galeazzi di Milano Sede di via Monreale18 (Istituto Clinico San Siro)
Milan, MI 20148
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.